<DOC>
	<DOCNO>NCT02870062</DOCNO>
	<brief_summary>The search preventive measure daily bath chlorhexidine critical care patient result reduction patient colonization multidrug resistant pathogen . Thus , prevent healthcare associate infection . The aim study determine impact daily bath chlorhexidine patient colonization , environment healthcare worker medical intensive care unit ( MICU ) . The study conduct University Hospital `` Dr. José Eleuterio González '' , 450-bed teaching hospital Monterrey , northeast Mexico . This prospective , experimental , randomize , open-label , double blind study compare chlorhexidine versus placebo . Any patient 18 year older admit MICU le 48 hour patient-days include . Patients present burn 20 % body surface , pregnant patient patient allergy history chlorhexidine . Samples obtain patient , patient environment healthcare personnel . Sampling environment ( bed rail , mechanical ventilator , table adjacent bed , etc . ) patient 's anogenital pharyngeal region collect `` swab '' technique use cotton swab culture accord Public Health England . Patient skin sample obtain anorectal region , pharynx , axillary inguinal fold collect Williamson-Kligman technique . Colonies select properly cultivate accord characteristic . Antibiotic susceptibility , clonal relationship , biofilm index antibiotic susceptibility chlorhexidine determine . Demographics clinical data collect admission , throughout hospitalization discharge .</brief_summary>
	<brief_title>Impact Daily Bathing With Chlorhexidine Critical Patient</brief_title>
	<detailed_description>Introduction : The search preventive measure daily bath chlorhexidine critical care patient result reduction patient colonization multidrug resistant pathogen . Thus , prevent healthcare associate infection . The aim study determine impact daily bath chlorhexidine patient colonization , environment healthcare worker medical intensive care unit ( MICU ) . Setting : The study conduct University Hospital `` Dr. José Eleuterio González '' , 450-bed teaching hospital Monterrey , northeast Mexico . The hospital average 22 23 thousand yearly discharge 20 bed 15 bed ICU adult pediatric/neonatal patient , respectively . Design method : This prospective , experimental , randomize , open-label , double blind study compare chlorhexidine versus placebo . The randomization occur 1:1 patient divide two group . The chlorhexidine group receive daily bath chlorhexidine wipe 2 % concentration ( CLORHEXI-WIPES ONE-STEP , G70 Antisepsis , León , México ) , plus oral spray chlorhexidine chlorhydrate 0.12 % . For scalp washing , chlorhexidine shampoo 0.12 % concentration apply . The placebo group , receive wipe component arm # 1 plus oral spray application component except chlorhexidine . For scalp , standard shampoo use . These product label smell product first arm . Any patient 18 year older admit MICU le 48 hour patient-days include . Patients present burn 20 % body surface , pregnant patient patient allergy history chlorhexidine . Included patient develop rash pruritus chlorhexidine bath , eliminate study . Two week previous start study , MICU personnel receive theoretical practical training , bath technique taught . Attendance personnel record skill surveil intervention . Bathing technique : Before use , wipe package need heat conventional microwave 10-12 second , provider instruction . With use globe , entire skin surface cover mandibular region foot , avoid contact mucous membrane anal , nasal urethral membrane . A circular motion implement bathing . For facial genital region , wipe wet dressing allow . The facial genital region first clean . Mouthwashes oral spray solution carry , try properly impregnate cheek , palate , pharynx tongue , let solution sit minute removal . A towel wipe use neck shoulder ; use side wipe anterior anatomical region side posterior region . A wipe use limb ( 4 total ) , use one side anterior region back side posterior region . A wipe designate buttock perianal region , avoid anal region . A wipe use torso , one dorsal region , one foot one reserve spare . For scalp washing , shampoo foam apply circular motion , try cover entire surface scalp , excess remove dry towel . Sampling : Samples obtain patient environment . Sampling environment ( bed rail , mechanical ventilator , table adjacent bed , etc . ) patient 's anogenital pharyngeal region collect `` swab '' technique use cotton swab culture accord Public Health England . Patient skin sample obtain anorectal region , pharynx , axillary inguinal fold collect Williamson-Kligman technique ; delimit area 3 cm2 subsequent application 1 ml unionized solution , proceed gently scrape area sterile spatula . This liquid retrieve pipette culture directly blood agar plate . Colonies select properly cultivate accord characteristic . Healthcare personnel sample also obtain pharynx , skin hand . All sample collect day admission MICU , first 72 hour , 10th day week discharge patient . In case healthcare worker , collect end workday . Isolate processing : Samples culture use conventional method : prime medium , colony take separately place Brucella broth 15 % glycerol . Specimens frozen -80ºC . When process isolates , conventional phenotypic identification method use . From primary isolate testing , correspond biochemical test select specie identification . When phenotypic test n't reach isolate identification , molecular base test gene amplification use . Antimicrobial susceptibility evaluate broth microdilution method accord protocol M07-A10 M100-S25 Clinical Laboratory Standards Institute ( CLSI ) guideline process automatized system ( SensititreAris 2X ) . Pathogen clonal relationship For clonal relationship , pulse file gel electrophoresis use . Band pattern analyze visually accord Tenover criterion . Data obtain analyzed statistical software . Polymerase chain reaction ( PCR ) gene amplification obtain analyze antibiotic resistance pattern specie . Pathogen biofilm production : Biofilm production determine crystal violet stain biofilm index obtain spectrophotometry . Pathogen susceptibility chlorhexidine : For determination minimum inhibitory concentration ( MIC ) chlorhexidine , agar dilution method apply accord protocol M07-A9 M100-S20 CLSI guideline . Isolates MIC value ≥90 , denote reduced susceptibility disinfectant . Clinical data follow-up : Demographics clinical data collect admission , throughout hospitalization discharge . Variables previous hospital admission previous year , previous surgery , history infection resistant pathogen , day hospital stay , instrumentation ( use foley catheter , mechanical ventilation central venous catheter ) clinical evolution evaluate Acute Physiology Chronic Health Evaluation ( APACHE-II ) Scale Assessment Positive Symptoms ( SAPS ) . Positive culture swab obtain healthcare worker resistant pathogen proceed reinforcement hand hygiene strengthen universal protection ( glove , face mask , etc ) . If positive Methicillin-resistant Staphylococcus aureus ( MRSA ) culture obtain , intranasal mupirocin treatment give 5 day negative culture achieve . Hospital Epidemiology team 's routine surveillance monitoring continue throughout study period . Rate healthcare associate infection compare , intervention . Surveillance healthcare associate infection follow Center Disease Control ( CDC ) guideline .</detailed_description>
	<mesh_term>Cross Infection</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<criteria>Any patient admit medical intensive care unit Any patient le 48 hour medical intensive care unit Patient 's age 18 year old Patients burn great 20 % body surface Pregnancy Patients record allergy history chlorhexidine Elimination Criteria : Patient refuse participation study Patient develop severe reaction chlorhexidine , define sudden appearance rash and/or pruritus .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Chlorhexidine bath</keyword>
	<keyword>Critical patient</keyword>
	<keyword>Healthcare associate infection</keyword>
	<keyword>Critical care environment</keyword>
	<keyword>Patient colonization</keyword>
</DOC>